echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Nature Cancer: Why do some people recover from deadly brain tumors without treatment?

    Nature Cancer: Why do some people recover from deadly brain tumors without treatment?

    • Last Update: 2022-08-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Neuroblastoma is the most common extracranial tumor in children and the most common tumor in infants and young children, also known as the king of childhood canc.


    MYC genes are a group of common oncogenes (divided into C-MYC, N-MYC, L-MYC), and many cancers rely on the abnormal expression of MYC as a transcription factor to promote the uncontrolled growth and proliferation of cancer cel.


    MYC genes are a group of common oncogenes (divided into C-MYC, N-MYC, L-MYC), and many cancers rely on the abnormal expression of MYC as a transcription factor to promote the uncontrolled growth and proliferation of cancer cel.


    Recently, a research team from Heidelberg University in Germany and the German Cancer Research Center published a research paper entitled: MYCN mediates cysteine ​​addiction and sensitizes neuroblastoma to ferroptosis in Nature Cancer , a sub-journal of Natur.


    Nature Cancer MYCN mediates cysteine ​​addiction and sensitizes neuroblastoma to ferroptosisMYCN mediates cysteine ​​addiction and sensitizes neuroblastoma to ferroptosis

    This study shows that MYCN-amplified neuroblastoma is highly dependent on cysteine ​​and sensitive to ferroptosis, and blocking cysteine ​​can promote ferroptosis in cancer cells and significantly inhibit tumor grow.


    The study also explains why a subset of infants and young children with neuroblastoma heal spontaneously without treatment -- when the cancer cells are rapidly dividing, they deplete cysteine ​​and trigger ferroptosis, thereby eliminating the cancer cel.


    It is well known that during the development of multicellular organisms, there are a variety of predetermined and precisely controlled programmed cell death, such as apoptosis (Apoptosis), programmed necrosis (Necroptosis), cell pyroptosis (Pyroptosis), and iron Death (Ferroptosis),e.


    Ferroptosis is a novel iron-dependent programmed cell death method discovered by the laboratory of Bre.


    At the same time, there are multiple defense pathways against ferroptosis in cells, the most important one of which is mediated by glutathione peroxidase 4 (GPX4), which is specifically catalyzed by glutathione (GS.


    Cancer cells are strongly dependent on certain amino acids due to their strong metabolic deman.


    Neuroblastoma cells with high MYCN expression are strongly dependent on the amino acid cysteine ​​(cysteine), and deprivation of cysteine ​​leads to massive death of cancer cells with high MYCN expressi.


    Therefore, when cysteine ​​uptake is limited, cysteine ​​is used in large quantities for protein synthesis, which triggers ferroptos.


    Neuroblastoma cells with high MYCN expression have a strong demand for cysteine, but restricting the intake of cysteine ​​does not completely block cysteine, because the intracellular can also be removed from methionine through transsulfati.


    Therefore, the research team adopted a three-pronged approach to simultaneously block cystine uptake, transsulfuration, and inhibit GPX4 in an orthotopic mouse tumor model of neuroblastoma with high MYCN expression, thereby completely blocking cysteine acid source and inhibited GPX4-mediated ferroptosis inhibiti.


    At the same time, the study provides an explanation for the puzzle that some infants and young children with neuroblastoma heal on their own, said Hamed Alborzinia, lead author of the pap.


    This study demonstrates that triggering ferroptosis significantly inhibits lethal neuroblastoma, suggesting that MYCN-driven tumor cells' high dependence on cysteine ​​is a novel therapeutic avenue that could be exploited to induce cancer cell dea.


    MYCN-driven high dependence of tumor cells on cysteine ​​is a novel therapeutic avenue that can be exploited to induce ferroptosis in cancer cells

     

    Original source:

    Original source:

    Alborzinia,.

    , Flórez, AF, Kreth,.

    et .

    MYCN mediates cysteine ​​addiction and sensitizes neuroblastoma to ferroptosi.

    Nat Cancer 3, 471–485 (202
    https://d.

    org/11038/s43018-022 -00355-

    Alborzinia,.

    , Flórez, AF, Kreth,.

    et .

    MYCN mediates cysteine ​​addiction and sensitizes neuroblastoma to ferroptosi.

    Nat Cancer 3, 471–485 (202
    https://d.

    org/11038/s43018-022 -00355- MYCN mediates cysteine ​​addiction and sensitizes neuroblastoma to ferroptosisLeave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.